acetylcysteine has been researched along with Genetic Predisposition in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, DR; Hansen, L; Joseph, G; Lyle, AN; Okwan-Duodu, D; Taylor, WR; Weiss, D | 1 |
| Bezerra, JA; Gutta, S; Luo, Z; Mourya, R; Shivakumar, P | 1 |
| Le, W; Xiao, Q; Yang, S | 1 |
| Anstrom, KJ; Huang, Y; Lee, C; Ma, SF; Martinez, FJ; Noth, I; Oldham, JM; Raghu, G; Schwartz, DA; Strek, ME; Valenzi, E; Vij, R; Witt, L | 1 |
| Lewis, JH; Stine, JG | 1 |
| Carbonari, D; Chiarella, P; Iavicoli, S; Mansi, A; Pigini, D; Tranfo, G | 1 |
| Chu, PY; Du, XJ; Giam, B; Horlock, D; Kaye, DM; Kiriazis, H; Kuruppu, S; Rajapakse, NW; Smith, AI | 1 |
| Halliwell, B; Hyun, DH; Jenner, P; Lee, M | 1 |
| Castoldi, AF; Coccini, T; Manzo, L; Prockop, LD | 1 |
| Barrett, JC; French, JE; Kari, FW; Martin, KR; Saulnier, M; Trempus, C | 1 |
| Thier, R | 1 |
4 review(s) available for acetylcysteine and Genetic Predisposition
| Article | Year |
|---|---|
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Antidotes; Antioxidants; Chelating Agents; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Genetic Predisposition to Disease; Humans; Liver Transplantation; Liver, Artificial; Patient Selection; Pharmacogenomic Testing; Phenotype; Precision Medicine; Risk Factors; Therapeutic Irrigation; Treatment Outcome | 2016 |
Biomarkers of susceptibility following benzene exposure: influence of genetic polymorphisms on benzene metabolism and health effects.
Topics: Acetylcysteine; Adult; Benzene; Biomarkers; Biotransformation; Carcinogenesis; Child; Cytochrome P-450 CYP2E1; Environmental Monitoring; Environmental Pollutants; Female; Genetic Predisposition to Disease; Glutathione Transferase; Humans; Male; Occupational Exposure; Oxidative Stress; Polymorphism, Genetic; Sorbic Acid | 2016 |
Assessing effects of neurotoxic pollutants by biochemical markers.
Topics: Acetylcholinesterase; Acetylcysteine; Aldehyde Dehydrogenase; Animals; Biomarkers; Calcium; Central Nervous System; Cholinesterases; Dopamine beta-Hydroxylase; Environmental Exposure; Environmental Pollutants; Genetic Predisposition to Disease; Humans; Monoamine Oxidase; Neurotoxins; Porphobilinogen Synthase; Porphyrins; Rats | 2001 |
Chemoprotection and interindividual differences in response to biological reactive intermediates.
Topics: Acetylcysteine; Acrylonitrile; Animals; Antidotes; Carcinogens; Free Radical Scavengers; Genetic Predisposition to Disease; Globins; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Hydrocarbons, Brominated; Isoenzymes; Molecular Epidemiology; Occupational Diseases; Occupational Exposure; Poisoning; Thiosulfates | 2001 |
7 other study(ies) available for acetylcysteine and Genetic Predisposition
| Article | Year |
|---|---|
Impaired Collateral Vessel Formation in Sickle Cell Disease.
Topics: Acetylcysteine; Anemia, Sickle Cell; Animals; Antioxidants; Blood Flow Velocity; Collateral Circulation; Disease Models, Animal; Female; Genetic Predisposition to Disease; Hindlimb; Hydrogen Peroxide; Ischemia; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Skeletal; Neovascularization, Physiologic; Neutrophils; Oxidative Stress; Phenotype; Regional Blood Flow; Time Factors | 2018 |
Gene Expression Signatures Associated With Survival Times of Pediatric Patients With Biliary Atresia Identify Potential Therapeutic Agents.
Topics: Acetylcysteine; Age Factors; Animals; Biliary Atresia; Case-Control Studies; Child, Preschool; Disease Models, Animal; Female; Gene Expression Profiling; Gene Regulatory Networks; Genetic Markers; Genetic Predisposition to Disease; Humans; Infant; Liver Transplantation; Male; Mice, Inbred BALB C; Phenotype; Predictive Value of Tests; Progression-Free Survival; Risk Assessment; Risk Factors; RNA, Messenger; Time Factors; Transcriptome; Treatment Outcome | 2019 |
G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system.
Topics: Acetylcysteine; Aging; Animals; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dopaminergic Neurons; Genetic Predisposition to Disease; Mice, Transgenic; Microglia; Motor Activity; Mutation; Neurodegenerative Diseases; Protein Serine-Threonine Kinases; Substantia Nigra; Tyrosine 3-Monooxygenase | 2015 |
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Topics: Acetylcysteine; Aged; Cohort Studies; Female; Genetic Predisposition to Disease; Humans; Idiopathic Pulmonary Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mucin-5B; Polymorphism, Single Nucleotide; Risk | 2015 |
N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure.
Topics: Acetylcysteine; Animals; Antioxidants; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Oxidative Stress; Phenotype; Protein Serine-Threonine Kinases; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Aldehydes; Apoptosis; Cell Death; Cell Line, Tumor; Drug Resistance; Enzyme Inhibitors; Genetic Predisposition to Disease; Glutamic Acid; Guanine; Humans; Hydrogen Peroxide; Mutation; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra; Tyrosine; Ubiquitin-Protein Ligases | 2005 |
Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice.
Topics: Acetylcysteine; Animals; Antioxidants; Benzo(a)pyrene; Carcinogens; Carcinoma, Squamous Cell; Cocarcinogenesis; Crosses, Genetic; Dietary Supplements; Female; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, ras; Genetic Predisposition to Disease; Haplotypes; Male; Mice; Mice, Transgenic; Skin Neoplasms; Transgenes; Tumor Suppressor Protein p53 | 2001 |